Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Muendlein, Axel ^a,b   Saely, Christoph H ^a,b,c   Geller Rhomberg, Simone ^a,b   Sonderegger, Gudrun ^a   Rein, Philipp ^a,b,c   Winder, Thomas ^a,b,c   Beer, Stefan ^a,b,c   Vonbank, Alexander ^a,b,c   Drexel, Heinz ^a,b,c,d  

^a Vorarlberg Institute for Vascular Investigation and Treatment   (Austria)

^b PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^c Academic Teaching Hospital Feldkirch   (Austria)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; TRANSCRIPTION FACTOR 7 LIKE 2; TCF7L2 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIABETIC PATIENT; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RADIOGRAPHY;

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 79952662422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017978     Document Type: Article

References (38)

1. Kannel WB, McGee DL, (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241: 2035-2038.
2. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, et al. (2008) Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database. Diabetologia 51: 1639-1645.
3. Barroso I, (2005) Genetics of Type 2 diabetes. Diabet Med 22: 517-535.
4. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U, (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330: 1041-1046.
5. Murabito JM, Pencina MJ, Nam BH, D'Agostino RB Sr, Wang TJ, et al. (2005) Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 294: 3117-3123.
6. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
7. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, et al. (2007) TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 85: 777-782.
8. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, et al. (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355: 241-250.
9. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55: 2890-2895.
10. Körner A, Berndt J, Stumvoll M, Kiess W, Kovacs P, (2007) TCF7L2 gene polymorphisms confer an increased risk for early impairment of glucose metabolism and increased height in obese children. J Clin Endocrinol Metab 92: 1956-1960.
11. Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, et al. (2007) TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 56: 1943-1947.
12. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, et al. (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117: 2155-2163.
13. Florez JC, (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51: 1100-1110.
14. Pearson ER, (2009) Translating TCF7L2: from gene to function. Diabetologia 52: 1227-1230.
15. Duval A, Busson-Leconiat M, Berger R, Hamelin R, (2000) Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet 88: 264-265.
16. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC, (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26: 898-915.
17. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, et al. (2006) Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 99: 1329-1337.
18. Venkiteswaran K, Xiao K, Summers S, Calkins CC, Vincent PA, et al. (2002) Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin. Am J Physiol Cell Physiol. 283: C811-C821.
19. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, et al. (2002) A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90: 340-347.
20. Bielinski SJ, Pankow JS, Folsom AR, North KE, Boerwinkle E, (2008) TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 51: 968-70.
21. Sousa AG, Marquezine GF, Lemos PA, Martinez E, Lopes N, et al. (2009) TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One 4: e7697.
22. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, et al. (2001) Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem 276: 42276-42286.
23. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I, (2007) Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. J Pathol 213: 35-45.
24. Mazzone T, Chait A, Plutzky J, (2008) Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371: 1800-1809.
25. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T, (2007) Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 193: 328-334.
26. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, et al. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269: 9889-9897.
27. Gable DR, Hurel SJ, Humphries SE, (2006) Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis 188: 231-44.
28. Marz W, Nauck M, Hoffmann MM, Nagel D, Boehm BO, et al. (2004) G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. Circulation 109: 2844-2849.
29. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572.
31. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
32. Judkins MP, (1967) Selective coronary arteriography: a percutaneous transfemoral technique. Radiology 89: 815-824.
33. Drexel H, Amann FW, Beran J, Rentsch K, Candinas R, et al. (1994) Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 90: 2230-2235.
34. Drexel H, Aczel S, Marte T, Benzer W, Langer P, et al. (2005) Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 28: 101-107.
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
36. Gaunt TR, Rodriguez S, Day IN, (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 8: 428.
37. Xie X, Ott, J, (1993) Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53: 1107.
38. Gauderman WJ, (2002) Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155: 478-484.